Financhill
Sell
46

SCPH Quote, Financials, Valuation and Earnings

Last price:
$3.32
Seasonality move :
-3.25%
Day range:
$3.30 - $3.47
52-week range:
$1.94 - $5.65
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
4.02x
P/B ratio:
10.87x
Volume:
272K
Avg. volume:
373.3K
1-year change:
-5.97%
Market cap:
$185M
Revenue:
$36.3M
EPS (TTM):
-$1.91

Earnings Data

Next earnings date for SCPH
Aug 14
2025
Most recent earnings per share
-$0.37
Missed by $0.09
(May 14/2025)
Consensus Estimate
-$0.29
(May 14/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

SCPH Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/14/2025 Q2 $15.4M -- -- -$0.30 --
05/14/2025 Q1 $11.6M $11.8M -$0.37 -$0.29 -$0.09
03/19/2025 Q4 $12.2M $12.2M -$0.35 -$0.39 $0.04
11/13/2024 Q3 $10.8M $10M -$0.75 -$0.30 -$0.45
08/14/2024 Q2 $8M $8.1M -$0.44 -$0.41 -$0.03
05/14/2024 Q1 $6M $6.1M -$0.36 -$0.43 $0.07
03/13/2024 Q4 $5.8M $6.1M -$0.35 -$0.41 $0.06
11/08/2023 Q3 -- -- -$0.41 -$0.37 -$0.04
08/10/2023 Q2 -- -- -$0.36 -$0.38 $0.02
05/10/2023 Q1 -- -- -$0.30 -$0.38 $0.08
03/22/2023 Q4 -- -- -$0.30 -$0.39 $0.09
11/09/2022 Q3 -- -- -$0.37 -$0.41 $0.04
08/09/2022 Q2 -- -- -$0.35 -$0.32 -$0.03
05/16/2022 Q1 -- -- -$0.28 -$0.29 $0.01
03/22/2022 Q4 -- -- -$0.27 -$0.34 $0.07
11/09/2021 Q3 -- -- -$0.24 -$0.32 $0.08
08/11/2021 Q2 -- -- -$0.26 -$0.30 $0.04
05/12/2021 Q1 -- -- -$0.26 -$0.30 $0.04
03/23/2021 Q4 -- -- -$0.28 -$0.37 $0.09
11/16/2020 Q3 -- -- -$0.33 -$0.37 $0.04
08/13/2020 Q2 -- -- -$0.36 -$0.42 $0.06
05/12/2020 Q1 -- -- -$0.35 -$0.54 $0.19
03/24/2020 Q4 -- -- -$0.58 -$0.52 -$0.06
11/12/2019 Q3 -- -- -$0.33 -$0.42 $0.09
08/07/2019 Q2 -- -- -$0.39 -$0.49 $0.10
05/08/2019 Q1 -- -- -$0.47 -$0.49 $0.02
03/21/2019 Q4 -- -- -$0.27 -$0.45 $0.18
11/13/2018 Q3 -- -- -$0.31 -$0.54 $0.23
08/14/2018 Q2 -- -- -$0.53 -$0.57 $0.03
05/07/2018 Q1 -- -- -$0.47 -$0.50 $0.03
03/20/2018 Q4 -- -- -$0.46 -$0.51 $0.05

scPharmaceuticals Earnings Questions

  • How Much did scPharmaceuticals Generate in Revenue Last Quarter?

    scPharmaceuticals reported $11.8M worth of top line sales in its most recent quarter.

  • Did scPharmaceuticals Beat Earnings Last Quarter?

    scPharmaceuticals announced earnings per share of -$0.37 which represents a miss of analyst forecast a -$0.29 per share.

  • Is scPharmaceuticals Profitable?

    scPharmaceuticals reported $8.3M that represents $0.15 per share over the last quarter.

  • What is the Analyst Consensus for scPharmaceuticals EPS Next Year?

    scPharmaceuticals's earnings are forecast to decrease from -$1.91 per share to -$1.78 per share next year representing a decrease of -47.02%.

  • When is scPharmaceuticals's Earnings Date?

    scPharmaceuticals's next earnings date is August 14, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will DigitalOcean Stock Bounce Back?
Will DigitalOcean Stock Bounce Back?

DigitalOcean (NYSE:DOCN) has run into the proverbial brick wall with…

Where Will Cognizant Stock Be In 5 Years?
Where Will Cognizant Stock Be In 5 Years?

Cognizant Technologies (NASDAQ:CTSH) is a global provider of IT services…

NVIDIA vs Broadcom Stock: Which Is Best?
NVIDIA vs Broadcom Stock: Which Is Best?

NVIDIA (NASDAQ:NVDA) and Broadcom (NASDAQ:AVGO) are two of the hottest…

Stock Ideas

Buy
65
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
65
Is NVDA Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 45x

Sell
33
Is AAPL Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 32x

Alerts

Buy
60
MRUS alert for May 24

Merus NV [MRUS] is up 32.55% over the past day.

Buy
57
RGC alert for May 24

Regencell Bioscience Holdings [RGC] is up 28.43% over the past day.

Buy
90
OKLO alert for May 24

Oklo [OKLO] is up 23.11% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock